|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Ullevaal University Hospital |
|---|---|
| Information provided by: | Oslo University Hospital |
| ClinicalTrials.gov Identifier: | NCT01019538 |
Purpose
The purpose of this study is to evaluate if supplemental oxygen during air travel can be reliably titrated using a Hypoxia-altitude simulation test (HAST). Also, the effect of oxygen supplementation given with the various oxygen equipment allowed for air travel is studied.
| Condition | Intervention |
|---|---|
|
Chronic Obstructive Pulmonary Disease |
Other: Pre-flight test with supplemental oxygen |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | COPD and Air Travel: Oxygen Equipment and Pre-flight Titration of Supplemental Oxygen |
Arterial blood gases
| Estimated Enrollment: | 20 |
| Study Start Date: | December 2008 |
| Study Completion Date: | April 2010 |
| Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
International guidelines recommend supplemental oxygen if PaO2 < 6.7 kPa (50 mmHg) during air travel. Hypobaric chamber exposure is the ideal test but is not widely available. In clinical practice, the HAST has been recommended as the preferable test for pre-flight evaluation, and is used with increasing frequency. The oxygen dose during air travel has been recommended titrated during HAST. In the study, supplemental oxygen titration during hypobaric chamber exposure is compared to oxygen titration during HAST, to evaluate if HAST can be used with confidence to titrate the amount of supplemental oxygen needed during air travel.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
COPD patients
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Norway | |
| Oslo University Hospital Ullevaal, Department of Pulmonary Medicine | |
| Oslo, Norway, 0407 | |
| Study Director: | Ole H Skjønsberg, Prof.dr.med | Oslo University Hospital Ullevaal |
| Principal Investigator: | Aina Akerø, M.D. | Oslo University Hospital Ullevaal |
More Information
| Responsible Party: | Ole Henning Skjønsberg, Prof., dr.med, Oslo University Hospital, Ullevaal, Department of Pulmonary Medicine |
| ClinicalTrials.gov Identifier: | NCT01019538 History of Changes |
| Other Study ID Numbers: | 897 |
| Study First Received: | November 23, 2009 |
| Last Updated: | July 3, 2011 |
| Health Authority: | Norway: The National Committees for Research Ethics in Norway |
|
Oxygen Hypoxemia Air travel |
|
Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Respiratory Tract Diseases |